In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling

Area of Science:

• Pharmacology
• Computational Chemistry
• Drug Discovery

Background:

• Traditionally, pharmacology relied on in vivo and in vitro models for structure-activity relationship studies.
• The field has a century-long history of correlating molecular structure with biological activity in the brain.

Observation:

• In silico methods, including databases, quantitative structure-activity relationships (QSAR), pharmacophores, and molecular modeling, have emerged over the last decade.
• These computational approaches are increasingly integrated with in vitro data for hypothesis generation and testing.

Findings:

• In silico tools facilitate the discovery and optimization of novel molecules targeting specific biological entities.
• They are crucial for predicting absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties, alongside physicochemical characterization.

Implications:

• Computational methods offer powerful, efficient alternatives and complements to traditional experimental approaches in drug discovery.
• The integration of in silico techniques enhances the speed and success rate of identifying and developing new therapeutics.